MACUSTAR
Official title: Development of novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (AMD)Trial start year: 2018
Design paper
2020
Clinical study protocol for a lowinterventional study in intermediate agerelated macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention - MACUSTAR
Download full paperResult paper
No result paper published